Dongu Bio "Bio Investments Bear Fruit… Results from Curient, D&D and Novacell Take Shape"
Predicted impact: Low· Actual: −4.5% vs sector, volume 1.8× normal (5 trading days)
Curient ADC deal with Lonza already reported in past 14 days; no size disclosed.